Nippon Shokubai Co., LTD has signed an agreement to take over Sirrus, Inc., an advanced reactive technology platform monomer company. The transaction is likely to be completed in March 2017. According to the agreement, Sirrus will continue to have the same management team with their current roles.
Sirrus, based in Loveland, OH, USA and founded as Bioformix in 2009, has developed cost-advantaged processes to produce reactive monomers at high purities. Monomer, diethyl methylene malonate, or DEMM, together with its derivatives, or MM-D, can be used in a variety of applications where faster cure times, lower solvent usage and legislation restrict the use of incumbent formulation components. Sirrus has developed a robust patent portfolio, consisting of over 25 global patents that address process technologies, methods of application, initiation, formulation and stabilization, as well as composition of matter for certain homopolymers, copolymers and hybrid polymers.
“It is rare to find a platform monomer company like Sirrus to provide best in class reactive monomers and materials to its customers”, said, Masanori Ikeda, President of Nippon Shokubai.“Combined with Sirrus’ intellectual property position, track record of innovation and access to a broad range of customers and applications, the transaction is a strong strategic fit for Nippon Shokubai”.
Sirrus, being a wholly owned operating subsidiary of Nippon Shokubai, will have access to additional resources to accelerate the development and commercialization of DEMM and MM-D, including in the areas of manufacturing, regulatory, capital planning and sales and marketing.
The long-term business plan “Reborn Nippon Shokubai 2
The long-term business plan “Reborn Nippon Shokubai 2020”, with improving as started by Nippon Shokubai in 2014 to create new core businesses in addition to its existing acrylic and superabsorbent business. DEMM and MM-D will be positioned as key strategic materials, and will accelerate new business development and global expansion.
Sirrus, formerly known as Bioformix, was founded in 2009 to commercialize efficient, high-performance monomers and derivatives. Sirrus technologies are energy with improved product performance for advanced manufacturing and assembly industries.